Recent Comments
- Bill on The Declaration of Pandemics
- Margaret McGregor on The Declaration of Pandemics
- admin on A Surgeon’s Story: Decision-making
- Margaret McGregor on A Surgeon’s Story: Decision-making
- LB on Has Bobby Kennedy’s campaign been infiltrated by intelligence operations?
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (17,475)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (15,802)
- New treatment paradigm for C. Diff colitis (14,777)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,751)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,205)
- How the FDA regulates compounding pharmacies (14,042)
- The Healthcare Channel hits 10 (13,523)
- The new CDC guidelines for prescribing opioid pain pills (9,044)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (8,538)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,263)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Pharma
TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it
March 23, 2019- Updated April 14, 2020 by Steven Greer Nobody has
Posted in - Pharma, Cardiology, CDC, FDA, Oncology
Comments Off on TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it
Are there any medications to treat coronavirus?
(Also: How infectious and lethal is this Coronavirus COVID-19 compared to regular “flu”?) February 27, 2020- by Steven E. Greer, MD Gilead makes a not-yet-approved antiviral drug called remdisivir and it is being tested right
Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Primary care medicine
2 Comments
President Trump adopts plan by The Healthcare Channel to bring back drug manufacturing jobs
Update February 26, 2020 By Steven E Greer, MD It is happening for real. Politico reports that the Trump administration is planning on using various
The ISCHEMIA trial PI, Judith Hochman, makes egregiously unfounded statements on national TV
November 17, 2019- by Steven E. Greer, MD The big news from the 2019 American Heart Association meeting is the large trial known by the acronym ISCHEMIA.
Posted in - Opinion, - Pharma, Cardiac surgery, Cardiology, Congress, FDA, Internal Medicine, NYU, VA
1 Comment
60 Minutes creates another publicist-paid puff-piece for an unethical medical researcher
December 8, 2019- by Steven E. Greer, MD CBS’ 60 Minutes featured an extremely unethical PhD medical researcher at Harvard named George
Essay: Opioids coming through the Mexican border are a national security risk
Update January 8, 2019- President Trump quoted from this story tonight during his talk from the Ova
Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, NIH, Primary care medicine, Rehab
Leave a comment
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,
Preventing HIV infection
July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper he co-wrote
Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome
January 20, 2016- Produced, Interviewed by Steven E. Greer, MD We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his
Posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard
Leave a comment
Paul Richardson, MD: Current Therapies for Multiple Myeloma
December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
Triple Therapy for Cystic Fibrosis
October 18, 2018- interviewed by Steven E. Greer, MD
BRAF and MEK combos for melanoma
Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
Steven E. Greer, MD, on CNBC discussing antidepressants
June 8, 2018– In the news recently are the suicide deaths of Kate Spade and Anthony Bourdain.
Posted in - Pharma, FDA, Psychology Psychiatry
Leave a comment
“You’re telling me this now?” Why the news is suddenly critical of statins and antidepressants
Opinion: February 19, 2012 By Steven Greer, MD The CBS news show “60 Minutes” made waves with a story asserting that the antidepressants
Once again, daily aspirin is shown to be deadly rather than beneficial
September 16, 2018- by Steven E. Greer, MD The Healthcare Channel has been pounding the table for many years pushing back against the drug
Industry conflicts arise at PCORI threatening any real comparative effectiveness research
February 7, 2014- By Steven E. Greer, MD The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010.
Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale
Leave a comment
Review of immunotherapy and targeted therapy
June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
The Year in Review: 2018
December 29, 2018- by Steven E. Greer, MD The biggest stories this year related
Insurance companies are not paying for Repatha and Praluent
Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.
Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis
January 31, 2017- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas
Leave a comment